97 related articles for article (PubMed ID: 19781916)
21. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
[TBL] [Abstract][Full Text] [Related]
22. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats.
Kokare DM; Dandekar MP; Chopde CT; Subhedar N
Brain Res; 2005 May; 1043(1-2):107-14. PubMed ID: 15862523
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy mediated seizure suppression in Genetic Generalised Epilepsy: Neuropeptide Y overexpression in a rat model.
Powell KL; Fitzgerald X; Shallue C; Jovanovska V; Klugmann M; Von Jonquieres G; O'Brien TJ; Morris MJ
Neurobiol Dis; 2018 May; 113():23-32. PubMed ID: 29414380
[TBL] [Abstract][Full Text] [Related]
24. Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice.
Hebb AL; Robertson HA; Denovan-Wright EM
Eur Neuropsychopharmacol; 2008 May; 18(5):339-63. PubMed ID: 17913473
[TBL] [Abstract][Full Text] [Related]
25. Effects of neuropeptide Y on sucrose and ethanol intake and on anxiety-like behavior in high alcohol drinking (HAD) and low alcohol drinking (LAD) rats.
Badia-Elder NE; Stewart RB; Powrozek TA; Murphy JM; Li TK
Alcohol Clin Exp Res; 2003 Jun; 27(6):894-9. PubMed ID: 12824809
[TBL] [Abstract][Full Text] [Related]
26. Unaltered neuropeptide Y (NPY)-stimulated [35S]GTPgammaS binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice.
Christensen DZ; Olesen MV; Kristiansen H; Mikkelsen JD; Woldbye DP
J Neurosci Res; 2006 Nov; 84(6):1282-91. PubMed ID: 16941487
[TBL] [Abstract][Full Text] [Related]
27. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
Tovote P; Meyer M; Beck-Sickinger AG; von Hörsten S; Ove Ogren S; Spiess J; Stiedl O
Regul Pept; 2004 Aug; 120(1-3):205-14. PubMed ID: 15177939
[TBL] [Abstract][Full Text] [Related]
28. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
Ishida H; Shirayama Y; Iwata M; Katayama S; Yamamoto A; Kawahara R; Nakagome K
Hippocampus; 2007; 17(4):271-80. PubMed ID: 17265460
[TBL] [Abstract][Full Text] [Related]
29. Modulation of neuropeptide Y and Y1 receptor expression in the amygdala by fluctuations in the brain content of neuroactive steroids during ethanol drinking discontinuation in Y1R/LacZ transgenic mice.
Eva C; Mele P; Collura D; Nai A; Pisu MG; Serra M; Biggio G
J Neurochem; 2008 Feb; 104(4):1043-54. PubMed ID: 18036156
[TBL] [Abstract][Full Text] [Related]
30. Neonatal thyroxine treatment: changes in the number of corticotropin-releasing-factor (CRF) and neuropeptide Y (NPY) containing neurons and density of tyrosine hydroxylase positive fibers (TH) in the amygdala correlate with anxiety-related behavior of wistar rats.
Yilmazer-Hanke DM; Hantsch M; Hanke J; Schulz C; Faber-Zuschratter H; Schwegler H
Neuroscience; 2004; 124(2):283-97. PubMed ID: 14980379
[TBL] [Abstract][Full Text] [Related]
31. The NPY system in stress, anxiety and depression.
Heilig M
Neuropeptides; 2004 Aug; 38(4):213-24. PubMed ID: 15337373
[TBL] [Abstract][Full Text] [Related]
32. Chronic psychosocial stress alters NPY system: different effects in rat and tree shrew.
Zambello E; Fuchs E; Abumaria N; Rygula R; Domenici E; Caberlotto L
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):122-30. PubMed ID: 19846047
[TBL] [Abstract][Full Text] [Related]
33. Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety.
Karl T; Burne TH; Herzog H
Behav Brain Res; 2006 Feb; 167(1):87-93. PubMed ID: 16203045
[TBL] [Abstract][Full Text] [Related]
34. Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior.
Slawecki CJ; Thorsell AK; El Khoury A; Mathé AA; Ehlers CL
Neuropeptides; 2005 Aug; 39(4):369-77. PubMed ID: 16038974
[TBL] [Abstract][Full Text] [Related]
35. Neuropeptide Y attenuates NMDA-induced phase shifts in the SCN of NPY Y1 receptor knockout mice in vitro.
Soscia SJ; Harrington ME
Brain Res; 2004 Oct; 1023(1):148-53. PubMed ID: 15364030
[TBL] [Abstract][Full Text] [Related]
36. Deletion of the neuropeptide Y Y1 receptor affects pain sensitivity, neuropeptide transport and expression, and dorsal root ganglion neuron numbers.
Shi TJ; Li J; Dahlström A; Theodorsson E; Ceccatelli S; Decosterd I; Pedrazzini T; Hökfelt T
Neuroscience; 2006 Jun; 140(1):293-304. PubMed ID: 16564642
[TBL] [Abstract][Full Text] [Related]
37. Anxiety-like behavior in transgenic mice with brain expression of neuropeptide Y.
Inui A; Okita M; Nakajima M; Momose K; Ueno N; Teranishi A; Miura M; Hirosue Y; Sano K; Sato M; Watanabe M; Sakai T; Watanabe T; Ishida K; Silver J; Baba S; Kasuga M
Proc Assoc Am Physicians; 1998; 110(3):171-82. PubMed ID: 9625524
[TBL] [Abstract][Full Text] [Related]
38. Changes in NPY-mediated modulation of hippocampal [3H]D-aspartate outflow in the kindling model of epilepsy.
Rodi D; Mazzuferi M; Bregola G; Dumont Y; Fournier A; Quirion R; Simonato M
Synapse; 2003 Aug; 49(2):116-24. PubMed ID: 12740867
[TBL] [Abstract][Full Text] [Related]
39. Estrus variation in anxiolytic-like effects of intra-lateral septal infusions of the neuropeptide Y in Wistar rats in two animal models of anxiety-like behavior.
Molina-Hernández M; Olivera-Lopez JI; Patricia Tellez-Alcántara N; Pérez-García J; Teresa Jaramillo M
Peptides; 2006 Nov; 27(11):2722-30. PubMed ID: 16806581
[TBL] [Abstract][Full Text] [Related]
40. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
Gehlert DR; Shaw JL
Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
